Marios Lazanas

924 total citations
23 papers, 374 citations indexed

About

Marios Lazanas is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Marios Lazanas has authored 23 papers receiving a total of 374 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Infectious Diseases, 9 papers in Virology and 9 papers in Epidemiology. Recurrent topics in Marios Lazanas's work include HIV Research and Treatment (9 papers), HIV/AIDS drug development and treatment (6 papers) and HIV/AIDS Research and Interventions (4 papers). Marios Lazanas is often cited by papers focused on HIV Research and Treatment (9 papers), HIV/AIDS drug development and treatment (6 papers) and HIV/AIDS Research and Interventions (4 papers). Marios Lazanas collaborates with scholars based in Greece, United States and France. Marios Lazanas's co-authors include Panagiotis Gargalianos, Helena C. Maltezou, Constantinos A. Demopoulos, Maria Chini, Panos Katerelos, Αλέξανδρος Τσούπρας, Paul Nikolaidis, Efstratios Maltezos, Antonios Maragos and Xanthi Dedoukou and has published in prestigious journals such as The Journal of Infectious Diseases, Life Sciences and International Journal of Environmental Research and Public Health.

In The Last Decade

Marios Lazanas

22 papers receiving 369 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Marios Lazanas Greece	9	158	150	97	91	36	23	374
Pasquale Spataro Italy	11	111 0.7×	77 0.5×	107 1.1×	22 0.2×	63 1.8×	21	367
Biao Zhu China	14	233 1.5×	262 1.7×	9 0.1×	47 0.5×	147 4.1×	69	584
Simbarashe Takuva South Africa	12	96 0.6×	290 1.9×	13 0.1×	182 2.0×	21 0.6×	33	412
Valentina Zuccaro Italy	13	101 0.6×	407 2.7×	14 0.1×	15 0.2×	81 2.3×	43	592
Augustine Ebonyi Nigeria	12	101 0.6×	141 0.9×	4 0.0×	38 0.4×	73 2.0×	31	583
Ferdinandus de Looze Australia	10	233 1.5×	39 0.3×	42 0.4×	15 0.2×	35 1.0×	17	466
Jocelyn Voell United States	8	185 1.2×	171 1.1×	13 0.1×	8 0.1×	46 1.3×	8	480
Álvaro Pereira Portugal	7	184 1.2×	117 0.8×	14 0.1×	6 0.1×	23 0.6×	11	339
Julio Desormeaux United States	8	254 1.6×	360 2.4×	8 0.1×	59 0.6×	17 0.5×	9	454
Osward M. Nyirenda United States	10	169 1.1×	210 1.4×	8 0.1×	22 0.2×	4 0.1×	21	406

Countries citing papers authored by Marios Lazanas

Since Specialization

Citations

This map shows the geographic impact of Marios Lazanas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marios Lazanas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marios Lazanas more than expected).

Fields of papers citing papers by Marios Lazanas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marios Lazanas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marios Lazanas. The network helps show where Marios Lazanas may publish in the future.

Co-authorship network of co-authors of Marios Lazanas

This figure shows the co-authorship network connecting the top 25 collaborators of Marios Lazanas. A scholar is included among the top collaborators of Marios Lazanas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marios Lazanas. Marios Lazanas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Souliotis, Kyriakos, et al.. (2022). Access of People Living with HIV to Testing Services in Greece: A Challenge for Equity in Care. International Journal of Environmental Research and Public Health. 19(21). 14353–14353.

Giamarellos‐Bourboulis, Evangelos J., George L. Daikos, Panagiotis Gargalianos, et al.. (2021). The Role of Macrolides for the Management of Community-Acquired Pneumonia and Pneumonia by the Novel Coronavirus SARS-CoV-2 (COVID-19): A Position Paper by Four Medical Societies from Greece. Infectious Diseases and Therapy. 10(3). 1081–1095. 2 indexed citations

Chini, Maria, et al.. (2016). Successful Treatment of Immune Reconstitution Inflammatory Syndrome-Related Hemophagocytic Syndrome in an HIV Patient with Primary Effusion Lymphoma. Hematology Reports. 8(4). 64–67. 8 indexed citations

Katerelos, Panos, et al.. (2013). Antibiotic prescription and knowledge about antibiotic costs of physicians in primary health care centers in Greece. American Journal of Infection Control. 41(12). 1296–1297. 6 indexed citations

Paraskevis, Dimitrios, Giota Touloumi, Giorgos Bakoyannis, et al.. (2012). Effect of HIV Type 1 Subtype on Virological and Immunological Response to Combination Antiretroviral Therapy: Evidence for a More Rapid Viral Suppression for Subtype A Than Subtype B-Infected Greek Individuals. AIDS Research and Human Retroviruses. 29(3). 461–469. 7 indexed citations

Chini, Maria, Αλέξανδρος Τσούπρας, Elizabeth Fragopoulou, et al.. (2011). Effects of HAART on Platelet-Activating Factor Metabolism in Naive HIV-Infected Patients I: Study of the Tenofovir-DF/Emtricitabine/Efavirenz HAART Regimen. AIDS Research and Human Retroviruses. 28(8). 766–775. 8 indexed citations

Chini, Maria, et al.. (2011). Calcific Myonecrosis of the Leg: Report of Three Patients Presenting with Infection. Surgical Infections. 12(3). 247–250. 7 indexed citations

Τσούπρας, Αλέξανδρος, Maria Chini, George Stamatakis, et al.. (2011). Platelet-Activating Factor and Its Basic Metabolic Enzymes in Blood of Naive HIV-Infected Patients. Angiology. 63(5). 343–352. 26 indexed citations

Maltezou, Helena C., Panagiotis Gargalianos, Paul Nikolaidis, et al.. (2011). Attitudes towards mandatory vaccination and vaccination coverage against vaccine-preventable diseases among health-care workers in tertiary-care hospitals. Journal of Infection. 64(3). 319–324. 65 indexed citations

10.

Τσούπρας, Αλέξανδρος, et al.. (2011). In vitro anti-inflammatory and anti-coagulant effects of antibiotics towards Platelet Activating Factor and thrombin. Journal of Inflammation. 8(1). 17–17. 16 indexed citations

11.

Maltezou, Helena C., Xanthi Dedoukou, Stavros Patrinos, et al.. (2010). Determinants of intention to get vaccinated against novel (pandemic) influenza A H1N1 among health-care workers in a nationwide survey. Journal of Infection. 61(3). 252–258. 59 indexed citations

12.

Τσούπρας, Αλέξανδρος, Maria Chini, Elizabeth Fragopoulou, et al.. (2008). Anti-Platelet-Activating Factor Effects of Highly Active Antiretroviral Therapy (HAART): A New Insight in the Drug Therapy of HIV Infection?. AIDS Research and Human Retroviruses. 24(8). 1079–1086. 35 indexed citations

13.

Paraskevis, Dimitrios, Emmanouil Magiorkinis, Gkikas Magiorkinis, et al.. (2007). Increasing Prevalence of HIV‐1 Subtype A in Greece: Estimating Epidemic History and Origin. The Journal of Infectious Diseases. 196(8). 1167–1176. 54 indexed citations

14.

Katsoulidou, Antigoni, Dimitrios Paraskevis, Vana Sypsa, et al.. (2004). Clinical evaluation of an HIV‐1 and HCV assay and demonstration of significant reduction of the HCV detection window before seroconversion. Transfusion. 44(1). 59–66. 6 indexed citations

15.

Touloumi, Giota, Όλγα Κατσαρού, George Chrysos, et al.. (2001). Virological and Immunological Response to HAART Therapy in a Community-Based Cohort of HIV-1-Positive Individuals. HIV Clinical Trials. 2(1). 6–16. 14 indexed citations

16.

Lazanas, Marios, et al.. (1990). Listeria monocytogenes endocarditis in a patient with a mechanical heart valve.. La Presse Médicale. 19(12). 1 indexed citations

17.

Perronne, Christian, et al.. (1990). [Zona in 50 patients infected by human immunodeficiency virus. Clinical manifestations and prognostic value].. PubMed. 19(16). 752–4. 3 indexed citations

18.

Lazanas, Marios, et al.. (1988). PAF of biological fluids in disease: I.V. Levels in blood in allergic reactions induced by drugs. Archives of Dermatological Research. 280(2). 124–126. 30 indexed citations

19.

Lazanas, Marios, et al.. (1988). Study of Digoxin as inhibitor of the in vivo effects of acetyl glyceryl ether phosphorycholine (AGEPC) in mice. Life Sciences. 42(6). 623–633. 4 indexed citations

20.

Ladas, Spiros D., et al.. (1983). Erythrocyte uroporphyrinogen‐I‐synthase activity in β‐thalassaemic patients. European Journal of Clinical Investigation. 13(6). 461–463. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact